Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03379246 · ClinicalTrials.gov registry record
Apical Support During Hysterectomy for Pelvic Organ Prolapse
A clinical trial, sponsored by TriHealth.
- Completed
- Registry status
- 236
- Enrollment target
NCT03379246: Completed study, sponsored by TriHealth.
NCT03379246 is a clinical trial that has completed, run by TriHealth. The registered enrollment target is 236 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03379246 has completed, sponsored by TriHealth.
- COMPLETED
- Registry status
- 236 participants
- Enrollment target
Study Summary
This is a retrospective chart review using TriHealth Electronic Privacy Identification Center (EPIC) to determine whether gynecologic surgeons at a large community hospital are already meeting the recently recommended best practice of supporting the vaginal apex.
Primary Outcome
proportion of patients who had concurrent apical support procedures performed
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 236 participants |
| Start Date | 2017-12-05 |
| Est. Completion | 2018-08-30 |
What the finished NCT03379246 record still lists
NCT03379246 is an observational study that tracks outcomes without assigning an intervention. The registered 236 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03379246 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03379246 about?
NCT03379246 is a clinical study titled "Apical Support During Hysterectomy for Pelvic Organ Prolapse". This is a retrospective chart review using TriHealth Electronic Privacy Identification Center (EPIC) to determine whether gynecologic surgeons at a large community hospital are already meeting the recently recommended best practice of supporting the vaginal apex.
What is the current status of trial NCT03379246?
This trial is currently completed. The enrollment target is 236 participants. The study started on 2017-12-05. Estimated completion is 2018-08-30.
Who is sponsoring clinical trial NCT03379246?
This trial is sponsored by TriHealth, which has 81 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04995341 · 236 participants · NA
Retinal Microanatomy in Retinopathy of Prematurity (BabySTEPS2)
- NCT05822362 · 236 participants · Phase 2
CBD for Individuals at Risk for Alzheimer's Disease
- NCT06200103 · 236 participants · Phase 2
Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer
- NCT06494072 · 236 participants · Phase 4
Short Versus Standard of Care Antibiotic Duration for Children Hospitalized for CAP
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI